Affomix Corporation

Affomix Corporation (Affomix) is an antibody technology company. The company provides a proprietary technology for rapid, automated, high-throughput methodologies selection of human monoclonal antibodies (mAbs) against unmodified as well as post-translationally modified proteins. Its current product offering includes Yeast two hybrids (Y2H) that increases the speed and specificity at which mAb selection and production can be carried out. The company commercializes proprietary mAbs, mAb microarrays and mAb libraries for research, drug discovery, diagnostic and therapeutic applications. Affomix, through its proprietary technologies will be able to generate the human Affome. The human Affome is a comprehensive set of mAbs that would help in detecting and quantifying all proteins in the human proteome. Affomix is headquartered in Connecticut, the US.

Street: 
688 East Main Street
City: 
Branford
Postcode: 
06405
Federal State : 
United States
WebSite: 
www.affomix.com
Fax: 
1-203-4880498

Company Index Score

Current Index Score Historical Index Score
  • Affomix Corporation currently scores 50 % in the index.
  • Affomix Corporation is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Affomix Corporation is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets